DOCSLIB.ORG

(Levonorgestrel) Tablets, 0.75 Mg

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(Levonorgestrel) Tablets, 0.75 Mg ©2005 Duramed Pharmaceuticals, Inc. Pharmaceuticals, Duramed ©2005 For Position Only Position For UPC Barcode UPC Visit our Web site at www.go2planb.com at site Web our Visit take the first tablet, the more effective it will be. will it effective more the tablet, first the take 24 hours a day/7 days a week. a days day/7 a hours 24 1-800-330-1271, call 72 hours (3 days) after unprotected sex. The sooner you you sooner The sex. unprotected after days) (3 hours 72 For more information or to speak to a healthcare professional, healthcare a to speak to or information more For take the first tablet as soon as possible but no later than than later no but possible as soon as tablet first the take ■ ■ Questions or comments? or Questions women 18 years of age and over: and age of years 18 women ■ Directions monohydrate, magnesium stearate, potato starch, talc starch, potato stearate, magnesium monohydrate, colloidal silicon dioxide, corn starch, gelatin, lactose lactose gelatin, starch, corn dioxide, silicon colloidal help or contact a Poison Control center right away. right center Control Poison a contact or help Inactive ingredients Inactive In case of overdose, get medical medical get overdose, of case In Keep out of reach of children. of reach of out Keep ° ° F) (68-77 C 20-25 at store ■ ■ headache pain breast menstrual changes menstrual ■ ■ ■ not use if these printed seals have either been removed or broken. or removed been either have seals printed these if use not dizziness diarrhea tiredness ■ ■ ■ Do B Plan with imprinted seals 2 with sealed is package this ■ ■ ®. stomach pain stomach vomiting nausea See condom labeling for additional STD information. STD additional for labeling condom See ■ ■ ■ you may have may you product this using When the risk of catching or spreading HIV, the virus that causes AIDS. AIDS. causes that virus the HIV, spreading or catching of risk the greatly reduce, but do not eliminate, the risk of pregnancy and and pregnancy of risk the eliminate, not do but reduce, greatly for regular birth control birth regular for ■ when used correctly every time you have sex, latex condoms condoms latex sex, have you time every correctly used when ■ if you are already pregnant (because it will not work) not will it (because pregnant already are you if ■ to the uterus (implantation). See consumer information leaflet. information consumer See (implantation). uterus the to Do not use not Do (joining of sperm and egg) or attachment of a fertilized egg egg fertilized a of attachment or egg) and sperm of (joining release). It may also prevent fertilization of a released egg egg released a of fertilization prevent also may It release). protect against HIV/AIDS or other STDs other or HIV/AIDS against protect not does this product works mainly by preventing ovulation (egg (egg ovulation preventing by mainly works product this This product product This alert: (STDs) diseases transmitted Sexually ■ used correctly. used reaction to levonorgestrel to reaction does not work as well as most other birth control methods methods control birth other most as well as work not does Do not use if you have ever had an allergic allergic an had ever have you if use not Do alert: Allergy this product is not recommended for regular birth control. It It control. birth regular for recommended not is product this ■ Warnings Warnings information leaflet for complete directions and information and directions complete for leaflet information before using this product read the enclosed consumer consumer enclosed the read product this using before ■ ■ (if a contraceptive failed or if you did not use birth control) birth use not did you if or failed contraceptive a (if Other information Other Use reduces chance of pregnancy after unprotected sex unprotected after pregnancy of chance reduces a healthcare professional. professional. healthcare a Emergency contraceptive Emergency .......... 0.75mg............ Levonorgestrel prescription only for age 17 and under. If age 17 or under, see see under, or 17 age If under. and 17 age for only prescription ■ Active ingredient (in each tablet) Purpose tablet) each (in ingredient Active after you take the first tablet first the take you after hours 12 tablet second the take ■ Drug Facts Drug (continued) Drug Facts Drug CM logo ® DIE# (LEVONORGESTRELLEVONORGESTREL) 2 Levonorgestrel Tablets tablets 0.75 mg 0.75 mg each Emergency Contraceptive Rx only for age 17 Emergency Contraceptive Emergency and younger ( LEVONORGESTREL L E V O N O tablets 0.75 mg tablets 0.75 ® R G E S T R E L ) ® Tablet 1 STD C128 SubSet C Date of Manufacture: (LEVONORGESTRELLEVONORGESTREL) Take the first Tablet 2 FPO Levonorgestrel Tablets Levonorgestrel 0.75 mg each 0.75 Expiration Date: tablets 0.75 mg tablet as soon as possible within 72 2 hours of unprotected FPO Emergency sex. The sooner you take the first tablet, the more Contraceptive effective Plan B® will be. STD C128 SubSet C ® ) Take the second tablet L E R 12 hours later. T S E G R tablets 0.75 mg tablets 0.75 Reduces the chance of pregnancy after unprotected sex O N O (ie, if a regular birth control method fails or after sex without V E LEVONORGESTREL L Levonorgestrel Tablets ( birth control). Not Intended To Replace Regular Birth Control. 2 Contraceptive Emergency Plan B® Should Be Used Only In Emergencies 0.75 mg each ® (LEVONORGESTRELLEVONORGESTREL) 2 Levonorgestrel Tablets tablets 0.75 mg 0.75 mg each Emergency Contraceptive DRUG FACTS TEXT DEFINED TYPE SIZE TYPE FONT • DRUG FACTS Title 9 pt Helvetica Bold Condensed Oblique • DRUG FACTS CONTINUED 8 pt Helvetica Bold Cond. Oblique/Helvetica Condensed 8 pt Helvetica Bold Condensed Oblique • HEADINGS 6 pt Helvetica Bold Condensed/Helvetica Condensed • SUBHEADS/BODY TEXT 7 pt • LEADING <39 • # OF CHARACTERS PER INCH 5 pt Zapf Dingbats • BULLETS 2 ems • SPACE AFTER BULLETED SECTION 1 pt, .5 pt • BARLINES, HAIRLINES 2 spaces • SPACE BETWEEN HAIRLINES AND BOX END Emergency Contraceptive Emergency tablets 0.75 mg 0.75 tablets L E R T S E G R O N O V E L For Position Only LEVONORGESTREL ) UPC Barcode ( STD C128 SubSet C FPO ® ® 1 Take first tablet as soon as possible, but no later than (LEVONORGESTREL) 72 hours (3 days) after unprotected sex. tablets 0.75 mg Tablet 1 2 Emergency Take second tablet Contraceptive 12 hours after Tablet taking first tablet. 2 Levonorgestrel Tablets TIME REMINDER 2 0.75 mg each Write on line below, the time the first tablet is taken. The sooner you take the first tablet, the Take second tablet more effective Plan B® will be 12 hours later. ___________AM/PM Not Intended To Replace Regular Birth Control (circle one) Plan B® Should Be Used Only In Emergencies LIFT Drug Facts Drug Facts (continued) Active ingredient (in each tablet) Purpose ■ take the second tablet 12 hours after you take the first tablet Levonorgestrel 0.75mg......................Emergency contraceptive ■ prescription only for age 17 and under. If age 17 or under, see a healthcare professional. Use reduces chance of pregnancy after unprotected sex Other information (if a contraceptive failed or if you did not use birth control) ■ before using this product read the enclosed consumer Warnings information leaflet for complete directions and information Allergy alert: Do not use if you have ever had an allergic ■ this product is not recommended for regular birth control. It reaction to levonorgestrel does not work as well as most other birth control methods used correctly. Sexually transmitted diseases (STDs) alert: This product ■ this product works mainly by preventing ovulation (egg STD C128 SubSet C does not protect against HIV/AIDS or other STDs release). It may also prevent fertilization of a released egg (joining of sperm and egg) or attachment of a fertilized egg Do not use FPO ■ to the uterus (implantation). See consumer information leaflet. if you are already pregnant (because it will not work) ■ ■ when used correctly every time you have sex, latex condoms for regular birth control greatly reduce, but do not eliminate, the risk of pregnancy and When using this product you may have the risk of catching or spreading HIV, the virus that causes AIDS. ■ nausea ■ vomiting ■ stomach pain See condom labeling for additional STD information. ■ tiredness ■ diarrhea ■ dizziness ■ this package is sealed with 2 seals imprinted with Plan B®. Do ■ menstrual changes ■ breast pain ■ headache not use if these printed seals have either been removed or broken. ■ store at 20-25°C (68-77°F) Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control center right away. Inactive ingredients colloidal silicon dioxide, corn starch, gelatin, lactose Directions monohydrate, magnesium stearate, potato starch, talc ■ women 18 years of age and over: Questions or comments? ■ take the first tablet as soon as possible but no later than For more information or to speak to a healthcare professional, 72 hours (3 days) after unprotected sex. The sooner you call 1-800-330-1271, 24 hours a day/7 days a week. take the first tablet, the more effective it will be. Visit our Web site at www.go2planb.com DRUG FACTS TEXT DEFINED TYPE SIZE TYPE FONT • DRUG FACTS Title 9 pt Helvetica Bold Condensed Oblique • DRUG FACTS CONTINUED 8 pt Helvetica Bold Cond. Oblique/Helvetica Condensed 8 pt Helvetica Bold Condensed Oblique • HEADINGS 6 pt Helvetica Bold Condensed/Helvetica Condensed • SUBHEADS/BODY TEXT 7 pt • LEADING <39 • # OF CHARACTERS PER INCH 5 pt Zapf Dingbats • BULLETS 2 ems • SPACE AFTER BULLETED SECTION 1 pt, .5 pt • BARLINES, HAIRLINES 2 spaces • SPACE BETWEEN HAIRLINES AND BOX END Please see enclosed important Product Information for Plan B®.
Load more

Recommended publications
  • Ocps) Used in the NM Family Planning Program (FPP
    The following slides are intended to familiarize nurses and clinicians with oral contraceptive pills (OCPs) used in the NM Family Planning Program (FPP). The FPP does not intend for this information to supersede the Family Planning Protocol particularly on the requirement for Public Health Nurses in the Public Health Offices to consult a clinician as stated in the Protocol when in doubt or if it is necessary to switch the client’s OCP type. 1 2 Combined oral contraceptives (COCs) contain two hormones; estrogen and progestin. In general, any combined OCP is good for most women who are eligible to take estrogen according to the CDC U.S. Medical Eligibility Criteria (MEC). Once again, refer to the US MEC chart to find out if OCP is a suitable choice for clients with specific health conditions. To learn a little bit about what each hormone does, the FPP is providing the following summary: Estrogen: provides endometrial stability = menstrual cycle control. A higher estrogen dose increases the venous thromboembolism (VTE) or clot risk but OCP clot risk is still less harmful than the clot risk related to pregnancy and giving birth. Progestin: provides most of the contraceptive effect by ‐Preventing luteinizing hormone (LH) surge /ovulation ‐Thickening the cervical mucus to prevent sperm entry. Two major OCP formations are available. Monophasic: There is only one dose of estrogen and progestin in each active pill in the packet; and Multiphasic: There are varying doses of hormones, particularly progestin in the active pills. 3 Section 3 of the FPP Protocol contains the OCP Substitute Table, which groups OCPs into 6 classes according to the estrogen dosage, the type of progestin and the formulations.
    [Show full text]
  • Comparing the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis In
    JMIR RESEARCH PROTOCOLS Amiri et al Review Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis Mina Amiri1,2, PhD, Postdoc; Fahimeh Ramezani Tehrani2, MD; Fatemeh Nahidi3, PhD; Ali Kabir4, MD, MPH, PhD; Fereidoun Azizi5, MD 1Students Research Committee, School of Nursing and Midwifery, Department of Midwifery and Reproductive Health, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic Of Iran 2Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic Of Iran 3School of Nursing and Midwifery, Department of Midwifery and Reproductive Health, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic Of Iran 4Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Islamic Republic Of Iran 5Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic Of Iran Corresponding Author: Fahimeh Ramezani Tehrani, MD Reproductive Endocrinology Research Center Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences 24 Parvaneh Yaman Street, Velenjak, PO Box 19395-4763 Tehran, 1985717413 Islamic Republic Of Iran Phone: 98 21 22432500 Email: [email protected] Abstract Background: Different products of combined oral contraceptives (COCs) can improve clinical and biochemical findings in patients with polycystic ovary syndrome (PCOS) through suppression of the hypothalamic-pituitary-gonadal (HPG) axis. Objective: This systematic review and meta-analysis aimed to compare the effects of COCs containing progestins with low androgenic and antiandrogenic activities on the HPG axis in patients with PCOS.
    [Show full text]
  • PMBJP Product.Pdf
    Sr. Drug Generic Name of the Medicine Unit Size MRP Therapeutic Category No. Code Analgesic & Antipyretic / Muscle 1 1 Aceclofenac 100mg and Paracetamol 325 mg Tablet 10's 10's 8.00 relaxants Analgesic & Antipyretic / Muscle 2 2 Aceclofenac Tablets IP 100mg 10's 10's 4.37 relaxants Acetaminophen 325 + Tramadol Hydrochloride 37.5 film Analgesic & Antipyretic / Muscle 3 4 10's 8.00 coated Tablet 10's relaxants Analgesic & Antipyretic / Muscle 4 5 ASPIRIN Tablets IP 150 mg 14's 14's 2.70 relaxants DICLOFENAC 50 mg+ PARACETAMOL 325 mg+ Analgesic & Antipyretic / Muscle 5 6 10's 11.30 CHLORZOXAZONE 500 mg Tablets 10's relaxants Diclofenac Sodium 50mg + Serratiopeptidase 10mg Tablet Analgesic & Antipyretic / Muscle 6 8 10's 12.00 10's relaxants Analgesic & Antipyretic / Muscle 7 9 Diclofenac Sodium (SR) 100 mg Tablet 10's 10's 6.12 relaxants Analgesic & Antipyretic / Muscle 8 10 Diclofenac Sodium 25mg per ml Inj. IP 3 ml 3 ml 2.00 relaxants Analgesic & Antipyretic / Muscle 9 11 Diclofenac Sodium 50 mg Tablet 10's 10's 2.90 relaxants Analgesic & Antipyretic / Muscle 10 12 Etoricoxilb Tablets IP 120mg 10's 10's 33.00 relaxants Analgesic & Antipyretic / Muscle 11 13 Etoricoxilb Tablets IP 90mg 10's 10's 25.00 relaxants Analgesic & Antipyretic / Muscle 12 14 Ibuprofen 400 mg + Paracetamol 325 mg Tablet 10's 15's 5.50 relaxants Analgesic & Antipyretic / Muscle 13 15 Ibuprofen 200 mg film coated Tablet 10's 10's 1.80 relaxants Analgesic & Antipyretic / Muscle 14 16 Ibuprofen 400 mg film coated Tablet 10's 15's 3.50 relaxants Analgesic & Antipyretic
    [Show full text]
  • Desogestrel-Only Pill (Cerazette)
    J Fam Plann Reprod Health Care: first published as 10.1783/147118903101197593 on 1 July 2003. Downloaded from Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit A unit funded by the FFPRHC and supported by the University of Aberdeen and SPCERH to provide guidance on evidence-based practice New Product Review (April 2003) Desogestrel-only Pill (Cerazette) Journal of Family Planning and Reproductive Health Care 2003; 29(3): 162–164 Evidence from a randomised trial has shown that a 75 mg (microgrammes) desogestrel pill inhibits ovulation in 97% of cycles. Thus, on theoretical grounds, we would expect the desogestrel pill to be more effective than existing progestogen- only pills (POPs). However, Pearl indices from clinical trials comparing it to a levonorgestrel POP were not significantly different. Therefore an evidence-based recommendation cannot be made that the desogestrel pill is different from other POPs in terms of efficacy, nor that it is similar to combined oral contraception (COC) in this respect. An evidence-based recommendation can be made that the desogestrel-only pill is similar to other POPs in terms of side effects and acceptability. The desogestrel-only pill is not recommended as an alternative to COC in routine practice, but provides a useful alternative for women who require oestrogen-free contraception. In clinical trials: l Ovulation was inhibited in 97% of cycles at 7 and 12 months after initiation. l The Pearl index was 0.41 per 100 woman-years, which was not significantly different from a levonorgestrel-only pill. However, the trial providing these data was too small to detect a clinically important difference.
    [Show full text]
  • ESTROSTEP Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*) *Ferrous Fumarate Tablets Are Not USP for Dissolution and Assay
    ESTROSTEP Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. ESTROSTEP® Fe (Each white triangular tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol; each white square tablet contains 1 mg norethindrone acetate and 30 mcg ethinyl estradiol; each white round tablet contains 1 mg norethindrone acetate and 35 mcg ethinyl estradiol; each brown tablet contains 75 mg ferrous fumarate.) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. DESCRIPTION ESTROSTEP® Fe is a graduated estrophasic oral contraceptive providing estrogen in a graduated sequence over a 21-day period with a constant dose of progestogen. ESTROSTEP Fe provides for a continuous dosage regimen consisting of 21 oral contraceptive tablets and seven ferrous fumarate tablets. The ferrous fumarate tablets are present to facilitate ease of drug administration via a 28-day regimen, are non-hormonal, and do not serve any therapeutic purpose. Each white triangle-shaped tablet contains 1 mg norethindrone acetate [(17 alpha)-17- (acetyloxy)-19-norpregna-4-en-20-yn-3-one] and 20 mcg ethinyl estradiol [(17 alpha)-19- norpregna-1,3,5(10)-trien-20-yne-3,17-diol]; each white square-shaped tablet contains 1 mg norethindrone acetate and 30 mcg ethinyl estradiol; and each white round tablet contains 1 mg norethindrone acetate and 35 mcg ethinyl estradiol. Each tablet also contains calcium stearate; lactose; microcrystalline cellulose; and starch. The structural formulas are as follows: Each brown tablet contains ferrous fumarate, mannitol, povidone, microcrystalline cellulose, sodium starch glycolate, magnesium stearate, sucralose and spearmint flavor.
    [Show full text]
  • Emergency Contraception
    Need more information? State of Illinois This document provides some very basic information about emergency Illinois Department of Public Health contraception and how it works. If EC is something you want to know more about, ask the hospital emergency personnel about their policy on EC or ask the sexual assault advocate for assistance in getting this information. Local Support/Assistance: What You Should Know About Emergency Contraception For more information, contact ILLINOIS DEPARTMENT OF PUBLIC HEALTH 535 W. Jefferson St. Springfield, IL 62761 217-782-5750 Women’s Health-line 888-522-1282 TTY (hearing impaired use only) 800-547-0466 www.idph.state.il.us Developed by the Illinois Department of Public Health in cooperation with the Illinois Coalition Against Sexual Assault Printed by Authority of the State of Illinois IOCI 0041-1 Illinois law provides that victims of sexual assault are entitled to If I am already pregnant, medically and factually accurate information about emergency contra - ception (EC) when they receive emergency care in a hospital. Under will EC hurt the fetus? the Sexual Assault Survivors Emergency Treatment Act (410 ILCS There is no evidence that EC causes birth defects. However, there 70/2.2), Illinois hospitals are required to have a policy in place regarding have been no studies specific to taking birth control at this dosage. emergency contraception. Individual hospital protocols must ensure What is known is that babies born to women who continue taking that each victim of sexual assault will receive medically and factually birth control pills before finding out they are pregnant do not have accurate written and oral information about emergency contraception; higher rates of birth defects.
    [Show full text]
  • Oral Contraceptives
    ORAL CONTRACEPTIVES STRENGTH DRUG ESTROGEN PROGESTIN (ESTROGEN/PROGESTIN) MONOPHASIC Aviane 28, Lessina, Lutera, Orsythia, Ethinyl estradiol Levonorgestrel 20mcg/0.1mg Sronyx† Beyaz*, YAZ Ethinyl estradiol Drospirenone 20mcg/3mg [Gianvi, Loryna, Vestura]† Brevicon, Modicon Ethinyl estradiol Norethindrone 35mcg/0.5mg [Necon 0.5/35, Nortrel 0.5/35]† Desogen Ethinyl estradiol Desogestrel 30mcg/0.15mg [Apri, Emoquette, Reclipsen, Solia]† Femcon Fe, Ovcon 35 Ethinyl estradiol Norethindrone 35mcg/0.4mg [Balziva, Briellyn, Philith, Vyfemla Zenchent, Zenchent Fe]† Loestrin 21 1/20, Loestrin Fe 1/20, Ethinyl estradiol Norethindrone acetate 20mcg/1mg Loestrin 24 Fe, Minastrin 24 Fe [Gildess Fe 1/20, Junel 1/20, Junel Fe 1/20, Larin 1/20, Larin Fe 1/20, Microgestin 1/20, Microgestin Fe 1/20]† Loestrin 21 1.5/30, Loestrin Fe 1.5/30 Ethinyl estradiol Norethindrone acetate 30mcg/1.5mg [Gildess Fe 1.5/30, Junel 1.5/30, Junel Fe 1.5/30, Microgestin 1.5/30, Microgestin Fe 1.5/30]† Lo/Ovral Ethinyl estradiol Norgestrel 30mcg/0.3mg [Cryselle, Low-Ogestrel]† Lybrel Ethinyl estradiol Levonorgestrel 20mcg/0.09mg [Amethyst]† [Altavera, Levora, Marlissa, Portia]† Ethinyl estradiol Levonorgestrel 30mcg/0.15mg Norinyl 1/35, Ortho-Novum 1/35 Ethinyl estradiol Norethindrone 35mcg/1mg [Alyacen 1/35, Cyclafem 1/35, Dasetta 1/35, Necon 1/35, Nortrel 1/35]† Necon 1/50, Norinyl 1/50 Mestranol Norethindrone 50mcg/1mg Ogestrel 0.5/50† Ethinyl estradiol Norgestrel 50mcg/0.5mg Ortho-Cyclen Ethinyl estradiol Norgestimate 35mcg/0.25mg [MonoNessa, Previfem, Sprintec]† Ovcon
    [Show full text]
  • ARANELLE- Norethindrone and Ethinyl Estradiol Teva Pharmaceuticals USA, Inc
    ARANELLE- norethindrone and ethinyl estradiol Teva Pharmaceuticals USA, Inc. ---------- Aranelle®(norethindrone and ethinyl estradiol tablets USP) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. DESCRIPTION Aranelle® 28-Day Regimen (norethindrone and ethinyl estradiol tablets USP) provides a continuous oral contraceptive regimen of 7 light yellow tablets, 9 white tablets, 5 more light yellow tablets, and then 7 peach tablets. Each light yellow tablet contains norethindrone, USP 0.5 mg and ethinyl estradiol, USP 0.035 mg, each white tablet contains norethindrone, USP 1 mg and ethinyl estradiol, USP 0.035 mg, and each peach tablet contains inert ingredients. Norethindrone, USP is a potent progestational agent with the chemical name 17- Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol, USP is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol. Their structural formulae follow. Norethindrone, USP Ethinyl Estradiol, USP The light yellow tablet contains the following inactive ingredients, D&C yellow no. 10 aluminum lake, lactose monohydrate, magnesium stearate, and pregelatinized starch. The white tablet contains the following inactive ingredients, lactose monohydrate, magnesium stearate, and pregelatinized starch. The inactive peach tablets contain the following inactive ingredients, anhydrous lactose, FD&C yellow no. 6 aluminum lake, magnesium stearate, microcrystalline cellulose, and pregelatinized starch. CLINICAL PHARMACOLOGY Combination oral contraceptives act by suppression of gonadotrophins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which may reduce the likelihood of implantation).
    [Show full text]
  • World Health Organization Model List of Essential Medicines, 21St List, 2019
    World Health Organizatio n Model List of Essential Medicines 21st List 2019 World Health Organizatio n Model List of Essential Medicines 21st List 2019 WHO/MVP/EMP/IAU/2019.06 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
    [Show full text]
  • Emergency Contraception
    AQ FREQUENTLY ASKED QUESTIONS FAQ114 fCONTRACEPTION Emergency Contraception • What is emergency contraception? • How does emergency contraception work? • What are the different types of emergency contraception? • What is the most effective form of emergency contraception? • How does the copper intrauterine device work? • What are the possible side effects of using the copper intrauterine device? • How do emergency contraception pills work? • How often can I use emergency contraception pills? • What are the possible side effects of taking emergency contraception pills? • Is there anything that decreases the effectiveness of emergency contraception pills? • How can I get emergency contraception as soon as possible? • How do I start or resume using a birth control method after taking emergency contraception pills? • Do I need follow-up care after using emergency contraception? • Glossary What is emergency contraception? Emergency contraception (EC) reduces the chance of pregnancy after unprotected sexual intercourse. Common situations in which EC could be used include forgetting to take several birth control pills in a row, having a condom break or slip off, or not using a birth control method during sex. It also can be used after a woman has been raped. How does emergency contraception work? Using EC does not cause an abortion. An abortion ends an existing pregnancy. EC prevents pregnancy from occurring. EC must be used soon after unprotected sexual intercourse to be effective. It does not work if pregnancy has already occurred. What are the different types of emergency contraception? There are two main types of EC: 1) the copper intrauterine device (IUD) and 2) EC pills. There are three types of EC pills: 1) ulipristal, 2) progestin-only pills, and 3) combined EC pills.
    [Show full text]
  • EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
    EUROPEAN PHARMACOPOEIA 10.0 Index 1. General notices......................................................................... 3 2.2.66. Detection and measurement of radioactivity........... 119 2.1. Apparatus ............................................................................. 15 2.2.7. Optical rotation................................................................ 26 2.1.1. Droppers ........................................................................... 15 2.2.8. Viscosity ............................................................................ 27 2.1.2. Comparative table of porosity of sintered-glass filters.. 15 2.2.9. Capillary viscometer method ......................................... 27 2.1.3. Ultraviolet ray lamps for analytical purposes............... 15 2.3. Identification...................................................................... 129 2.1.4. Sieves ................................................................................. 16 2.3.1. Identification reactions of ions and functional 2.1.5. Tubes for comparative tests ............................................ 17 groups ...................................................................................... 129 2.1.6. Gas detector tubes............................................................ 17 2.3.2. Identification of fatty oils by thin-layer 2.2. Physical and physico-chemical methods.......................... 21 chromatography...................................................................... 132 2.2.1. Clarity and degree of opalescence of
    [Show full text]
  • Emergency Contraception Krishna K
    POLICY STATEMENT Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of all Children Emergency Contraception Krishna K. Upadhya, MD, MPH, FAAP, COMMITTEE ON ADOLESCENCE Despite significant declines over the past 2 decades, the United States abstract continues to experience birth rates among teenagers that are significantly higher than other high-income nations. Use of emergency contraception (EC) within 120 hours after unprotected or underprotected intercourse can reduce the risk of pregnancy. Emergency contraceptive methods include oral Children’s National Health System, Washington, District of Columbia medications labeled and dedicated for use as EC by the US Food and Drug Policy statements from the American Academy of Pediatrics benefit Administration (ulipristal and levonorgestrel), the “off-label” use of combined from expertise and resources of liaisons and internal (AAP) and external reviewers. However, policy statements from the American oral contraceptives, and insertion of a copper intrauterine device. Indications Academy of Pediatrics may not reflect the views of the liaisons or the for the use of EC include intercourse without use of contraception; condom organizations or government agencies that they represent. breakage or slippage; missed or late doses of contraceptives, including the Dr Upadhya was responsible for all aspects of revising and writing the policy statement with input from reviewers and the Board of Directors; oral contraceptive pill, contraceptive patch, contraceptive ring, and injectable she approves the final manuscript as submitted. contraception; vomiting after use of oral contraceptives; and sexual assault. The guidance in this statement does not indicate an exclusive course Our aim in this updated policy statement is to (1) educate pediatricians and of treatment or serve as a standard of medical care.
    [Show full text]